BACKGROUND: Occlusion therapy for amblyopia is predicated on the idea that amblyopia is primarily a disorder of monocular vision; however, there is growing evidence that patients with amblyopia have a structurally intact binocular visual system that is rendered functionally monocular due to suppression. Furthermore, we have found that a dichoptic treatment intervention designed to directly target suppression can result in clinically significant improvement in both binocular and monocular visual function in adult patients with amblyopia. The fact that monocular improvement occurs in the absence of any fellow eye occlusion suggests that amblyopia is, in part, due to chronic suppression. Previously the treatment has been administered as a psychophysical task and more recently as a video game that can be played on video goggles or an iPod device equipped with a lenticular screen. The aim of this case-series study of 14 amblyopes (six strabismics, six anisometropes and two mixed) ages 13 to 50 years was to investigate: 1. whether the portable video game treatment is suitable for at-home use and 2. whether an anaglyphic version of the iPod-based video game, which is more convenient for at-home use, has comparable effects to the lenticular version. METHODS: The dichoptic video game treatment was conducted at home and visual functions assessed before and after treatment. RESULTS: We found that at-home use for 10 to 30 hours restored simultaneous binocular perception in 13 of 14 cases along with significant improvements in acuity (0.11 ± 0.08 logMAR) and stereopsis (0.6 ± 0.5 log units). Furthermore, the anaglyph and lenticular platforms were equally effective. In addition, the iPod devices were able to record a complete and accurate picture of treatment compliance. CONCLUSION: The home-based dichoptic iPod approach represents a viable treatment for adults with amblyopia.
BACKGROUND: Occlusion therapy for amblyopia is predicated on the idea that amblyopia is primarily a disorder of monocular vision; however, there is growing evidence that patients with amblyopia have a structurally intact binocular visual system that is rendered functionally monocular due to suppression. Furthermore, we have found that a dichoptic treatment intervention designed to directly target suppression can result in clinically significant improvement in both binocular and monocular visual function in adult patients with amblyopia. The fact that monocular improvement occurs in the absence of any fellow eye occlusion suggests that amblyopia is, in part, due to chronic suppression. Previously the treatment has been administered as a psychophysical task and more recently as a video game that can be played on video goggles or an iPod device equipped with a lenticular screen. The aim of this case-series study of 14 amblyopes (six strabismics, six anisometropes and two mixed) ages 13 to 50 years was to investigate: 1. whether the portable video game treatment is suitable for at-home use and 2. whether an anaglyphic version of the iPod-based video game, which is more convenient for at-home use, has comparable effects to the lenticular version. METHODS: The dichoptic video game treatment was conducted at home and visual functions assessed before and after treatment. RESULTS: We found that at-home use for 10 to 30 hours restored simultaneous binocular perception in 13 of 14 cases along with significant improvements in acuity (0.11 ± 0.08 logMAR) and stereopsis (0.6 ± 0.5 log units). Furthermore, the anaglyph and lenticular platforms were equally effective. In addition, the iPod devices were able to record a complete and accurate picture of treatment compliance. CONCLUSION: The home-based dichoptic iPod approach represents a viable treatment for adults with amblyopia.
Authors: Tina Y Gao; Cindy X Guo; Raiju J Babu; Joanna M Black; William R Bobier; Arijit Chakraborty; Shuan Dai; Robert F Hess; Michelle Jenkins; Yannan Jiang; Lisa S Kearns; Lionel Kowal; Carly S Y Lam; Peter C K Pang; Varsha Parag; Roberto Pieri; Rajkumar Nallour Raveendren; Jayshree South; Sandra Elfride Staffieri; Angela Wadham; Natalie Walker; Benjamin Thompson Journal: JAMA Ophthalmol Date: 2018-02-01 Impact factor: 7.389
Authors: Simone L Li; Alexandre Reynaud; Robert F Hess; Yi-Zhong Wang; Reed M Jost; Sarah E Morale; Angie De La Cruz; Lori Dao; David Stager; Eileen E Birch Journal: J AAPOS Date: 2015-10 Impact factor: 1.220
Authors: Simone L Li; Reed M Jost; Sarah E Morale; Angie De La Cruz; Lori Dao; David Stager; Eileen E Birch Journal: JAMA Ophthalmol Date: 2015-04 Impact factor: 7.389
Authors: Indu Vedamurthy; Mor Nahum; Samuel J Huang; Frank Zheng; Jessica Bayliss; Daphne Bavelier; Dennis M Levi Journal: Vision Res Date: 2015-04-24 Impact factor: 1.886
Authors: María Begoña Coco-Martin; Pedro L Valenzuela; Miguel J Maldonado-López; Alejandro Santos-Lozano; Ainhoa Molina-Martín; David P Piñero Journal: Int J Ophthalmol Date: 2019-11-18 Impact factor: 1.779
Authors: Vivian M Manh; Jonathan M Holmes; Elizabeth L Lazar; Raymond T Kraker; David K Wallace; Marjean T Kulp; Jennifer A Galvin; Birva K Shah; Patricia L Davis Journal: Am J Ophthalmol Date: 2017-11-28 Impact factor: 5.258
Authors: Krista R Kelly; Reed M Jost; Lori Dao; Cynthia L Beauchamp; Joel N Leffler; Eileen E Birch Journal: JAMA Ophthalmol Date: 2016-12-01 Impact factor: 7.389